Cargando…

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells

Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle arrest frequently characterized by a bi- or multinuclear phenotype that is considered as a barrier to cancer progression. However, the long-sustained conviction that senescence is a truly irreversibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Leikam, C, Hufnagel, A L, Otto, C, Murphy, D J, Mühling, B, Kneitz, S, Nanda, I, Schmid, M, Wagner, T U, Haferkamp, S, Bröcker, E-B, Schartl, M, Meierjohann, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650540/
https://www.ncbi.nlm.nih.gov/pubmed/25837487
http://dx.doi.org/10.1038/cddis.2015.71
_version_ 1782401511095009280
author Leikam, C
Hufnagel, A L
Otto, C
Murphy, D J
Mühling, B
Kneitz, S
Nanda, I
Schmid, M
Wagner, T U
Haferkamp, S
Bröcker, E-B
Schartl, M
Meierjohann, S
author_facet Leikam, C
Hufnagel, A L
Otto, C
Murphy, D J
Mühling, B
Kneitz, S
Nanda, I
Schmid, M
Wagner, T U
Haferkamp, S
Bröcker, E-B
Schartl, M
Meierjohann, S
author_sort Leikam, C
collection PubMed
description Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle arrest frequently characterized by a bi- or multinuclear phenotype that is considered as a barrier to cancer progression. However, the long-sustained conviction that senescence is a truly irreversible process has recently been challenged. Still, it is not known whether cells driven into OIS can progress to cancer and thereby pose a potential threat. Here, we show that prolonged expression of the melanoma oncogene N-RAS(61K) in pigment cells overcomes OIS by triggering the emergence of tumor-initiating mononucleated stem-like cells from senescent cells. This progeny is dedifferentiated, highly proliferative, anoikis-resistant and induces fast growing, metastatic tumors. Our data describe that differentiated cells, which are driven into senescence by an oncogene, use this senescence state as trigger for tumor transformation, giving rise to highly aggressive tumor-initiating cells. These observations provide the first experimental in vitro evidence for the evasion of OIS on the cellular level and ensuing transformation.
format Online
Article
Text
id pubmed-4650540
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46505402015-12-01 In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells Leikam, C Hufnagel, A L Otto, C Murphy, D J Mühling, B Kneitz, S Nanda, I Schmid, M Wagner, T U Haferkamp, S Bröcker, E-B Schartl, M Meierjohann, S Cell Death Dis Original Article Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle arrest frequently characterized by a bi- or multinuclear phenotype that is considered as a barrier to cancer progression. However, the long-sustained conviction that senescence is a truly irreversible process has recently been challenged. Still, it is not known whether cells driven into OIS can progress to cancer and thereby pose a potential threat. Here, we show that prolonged expression of the melanoma oncogene N-RAS(61K) in pigment cells overcomes OIS by triggering the emergence of tumor-initiating mononucleated stem-like cells from senescent cells. This progeny is dedifferentiated, highly proliferative, anoikis-resistant and induces fast growing, metastatic tumors. Our data describe that differentiated cells, which are driven into senescence by an oncogene, use this senescence state as trigger for tumor transformation, giving rise to highly aggressive tumor-initiating cells. These observations provide the first experimental in vitro evidence for the evasion of OIS on the cellular level and ensuing transformation. Nature Publishing Group 2015-04 2015-04-02 /pmc/articles/PMC4650540/ /pubmed/25837487 http://dx.doi.org/10.1038/cddis.2015.71 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Leikam, C
Hufnagel, A L
Otto, C
Murphy, D J
Mühling, B
Kneitz, S
Nanda, I
Schmid, M
Wagner, T U
Haferkamp, S
Bröcker, E-B
Schartl, M
Meierjohann, S
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title_full In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title_fullStr In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title_full_unstemmed In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title_short In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
title_sort in vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650540/
https://www.ncbi.nlm.nih.gov/pubmed/25837487
http://dx.doi.org/10.1038/cddis.2015.71
work_keys_str_mv AT leikamc invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT hufnagelal invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT ottoc invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT murphydj invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT muhlingb invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT kneitzs invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT nandai invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT schmidm invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT wagnertu invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT haferkamps invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT brockereb invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT schartlm invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells
AT meierjohanns invitroevidenceforsenescentmultinucleatedmelanocytesasasourcefortumorinitiatingcells